Rolf Stahel
Founder presso Chesyl Pharma Ltd.
Profilo
Rolf Stahel is the founder and the Executive Chairman of Chesyl Pharma Ltd., which was founded in 1994.
He is also the Non-Executive Chairman of Ampha Ltd., starting in 2016.
Mr. Stahel's former positions include being the Chief Executive Officer of Shire Pharmaceuticals, Inc. from 1994 to 2003, the Non-Executive Chairman of EUSA Pharma, Inc., the Chairman of Cosmo Pharmaceuticals SA from 2006 to 2010, the Non-Executive Chairman of PowderMed Ltd.
in 2006, the Non-Executive Chairman of Newron Pharmaceuticals SpA from 2012 to 2013, the Deputy Chairman of Cosmo Holding SpA in 2007, the Non-Executive Chairman of Connexios Life Sciences Pvt Ltd.
from 2009 to 2016, the Non-Executive Chairman of Ergomed Plc from 2014 to 2017, the Non-Executive Chairman of Biodexa Pharmaceuticals Plc from 2014 to 2022, and the Director-Group Marketing of Wellcome Plc from 1967 to 1994.
Mr. Stahel's education includes an undergraduate degree from Kantons-schule.
Posizioni attive di Rolf Stahel
Società | Posizione | Inizio |
---|---|---|
Chesyl Pharma Ltd. | Founder | 01/03/1994 |
Ampha Ltd.
Ampha Ltd. Pharmaceuticals: MajorHealth Technology Ampha Ltd. manufactures pharmaceutical products. The private company is based in Kirtlington, UK. | Chairman | 01/12/2016 |
Precedenti posizioni note di Rolf Stahel
Società | Posizione | Fine |
---|---|---|
BIODEXA PHARMACEUTICALS PLC | Chairman | 20/06/2022 |
ERGOMED | Chairman | 01/03/2017 |
Connexios Life Sciences Pvt Ltd.
Connexios Life Sciences Pvt Ltd. Pharmaceuticals: GenericHealth Technology Connexios Life Sciences Pvt Ltd. discovers and develops small molecule therapeutics. It focuses on developing therapies that address the cellular pathology underlying metabolic diseases such as type 2 diabetes and non alcoholic steatohepatitis leading to chronic liver disease. The company was founded by Suri Venkatachalam in July 2003 and is headquartered in Bangalore, India. | Chairman | 01/01/2016 |
NEWRON PHARMACEUTICALS S.P.A. | Chairman | 18/04/2013 |
Cosmo Holding SpA
Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Cosmo Holding SpA manufactures and markets pharmaceutical products. It develops technologies in the sector of modified drug release with oral, topical, and transmucosal applications. The company was founded in 1996 and is headquartered in Milan, Italy. | Director/Board Member | 01/01/2007 |
Formazione di Rolf Stahel
Kantons-schule | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
NEWRON PHARMACEUTICALS S.P.A. | Health Technology |
ERGOMED | Commercial Services |
BIODEXA PHARMACEUTICALS PLC | Health Technology |
Aziende private | 9 |
---|---|
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Health Technology |
Cosmo Pharmaceuticals SA
Cosmo Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cosmo Pharmaceuticals SA operates as a pharmaceutical company that engages in the manufacturing of pharmaceutical drugs. It focuses on the development of gastro-intestinal pharmaceutical products for the treatment of inflammatory bowel diseases, colon infections and colon diagnosis, and treated skin disorders. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Lainate, Italy. | Health Technology |
Wellcome Plc
Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Wellcome Plc is a British company that specializes in the discovery, development, manufacture, and sale of human healthcare products. The private company is based in Greenford, UK. | Commercial Services |
PowderMed Ltd.
PowderMed Ltd. Pharmaceuticals: MajorHealth Technology PowderMed Ltd. develops immunotherapeutic products. It focuses on the clinical development and manufacture of therapeutic and prophylactic DNA-based vaccines for viral diseases and cancer. The company has 4 clinical and 3 pre-clinical stage projects. The company was founded February 25, 2004 by Dr. Clive Dix & Dr. Beadle and is headquartered at Oxford, The United Kingdom. | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
Cosmo Holding SpA
Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Cosmo Holding SpA manufactures and markets pharmaceutical products. It develops technologies in the sector of modified drug release with oral, topical, and transmucosal applications. The company was founded in 1996 and is headquartered in Milan, Italy. | Health Technology |
Chesyl Pharma Ltd. | |
Connexios Life Sciences Pvt Ltd.
Connexios Life Sciences Pvt Ltd. Pharmaceuticals: GenericHealth Technology Connexios Life Sciences Pvt Ltd. discovers and develops small molecule therapeutics. It focuses on developing therapies that address the cellular pathology underlying metabolic diseases such as type 2 diabetes and non alcoholic steatohepatitis leading to chronic liver disease. The company was founded by Suri Venkatachalam in July 2003 and is headquartered in Bangalore, India. | Health Technology |
Ampha Ltd.
Ampha Ltd. Pharmaceuticals: MajorHealth Technology Ampha Ltd. manufactures pharmaceutical products. The private company is based in Kirtlington, UK. | Health Technology |
- Borsa valori
- Insiders
- Rolf Stahel